Skip to search formSkip to main contentSkip to account menu

Novantrone

Known as: Novantron, Ralenova 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Mitochondria has an essential role in myocardial tissue homeostasis; thus deterioration in mitochondrial function eventually… 
Highly Cited
2011
Highly Cited
2011
Multiple sclerosis (MS) is a chronic inflammatory autoimmune demyelinating disease of the central nervous system. It affects… 
Review
2010
Review
2010
Objective: The chemotherapeutic agent mitoxantrone was approved for use in multiple sclerosis (MS) in 2000. After a review of all… 
Review
2006
Review
2006
  • E. Fox
  • Clinical therapeutics
  • 2006
  • Corpus ID: 26012431
Review
2003
Review
2003
Mitoxantrone is the first drug approved for the treatment of secondary progressive multiple sclerosis (SPMS) in the United States… 
Review
2002
Review
2002
Understanding of the etiology and pathogenesis of MS has improved significantly in recent years. In addition, important… 
Review
2002
Review
2002
Background Mitoxantrone (MITO) is associated with dose-related cardiotoxicity when administered concomitantly with other… 
Review
1994
Review
1994
Highly Cited
1985